Afya Ltd has a consensus price target of $19 based on the ratings of 8 analysts. The high is $23 issued by Morgan Stanley on January 22, 2024. The low is $15 issued by Citigroup on January 31, 2025. The 3 most-recent analyst ratings were released by Citigroup, JP Morgan, and Goldman Sachs on January 31, 2025, January 17, 2025, and December 3, 2024, respectively. With an average price target of $17.17 between Citigroup, JP Morgan, and Goldman Sachs, there's an implied 6.30% upside for Afya Ltd from these most-recent analyst ratings.
1calculated from analyst ratings
The latest price target for Afya (NASDAQ:AFYA) was reported by Citigroup on January 31, 2025. The analyst firm set a price target for $15.00 expecting AFYA to fall to within 12 months (a possible -7.12% downside). 5 analyst firms have reported ratings in the last year.
The latest analyst rating for Afya (NASDAQ:AFYA) was provided by Citigroup, and Afya downgraded their sell rating.
The last upgrade for Afya Ltd happened on October 13, 2023 when Morgan Stanley raised their price target to $20.5. Morgan Stanley previously had an equal-weight for Afya Ltd.
The last downgrade for Afya Ltd happened on January 31, 2025 when Citigroup changed their price target from $18 to $15 for Afya Ltd.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Afya, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Afya was filed on January 31, 2025 so you should expect the next rating to be made available sometime around January 31, 2026.
While ratings are subjective and will change, the latest Afya (AFYA) rating was a downgraded with a price target of $18.00 to $15.00. The current price Afya (AFYA) is trading at is $16.15, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.